Lupin CEO And MD On Best-In-Class Innovation, Top Spot Ambition And Father’s Legacy - Clone

Lupin’s CEO Vinita Gupta and MD Nilesh Gupta outline the company’s innovation agenda, strategy on GLP-1 drugs including fortnightly candidate bofanglutide, plans to get to number one in the domestic market and the legacy of their father in this podcast interview.

Lupin founder Desh Bandhu Gupta, in creating a company that licensed oncology assets to big pharma firms like AbbVie and Boehringer Ingelheim, set an agenda for innovation and partnering that continue to define the Indian company’s management vision to this day.

CEO Vinita Gupta and managing director Nilesh Gupta, in their first-ever podcast interview, spoke to Scrip about efforts to develop...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from HBW Insight

EU JCA: Milestone Report Shows Room For Improvement For Orphan Drugs And PICOs

In a major milestone for the EU’s pricing and reimbursement landscape, the European Commission has published the first ever, much anticipated, joint clinical assessment report.

Nancy Tests Infogram PDF

 

Description goes here.

Type:DataArticle | Publication:HBW | Section:Health | Paywall:Premium — Article containing all Composer content for testing (Do not update)

 
• By 

To make your document look professionally produced, Word provides header, footer, cover page, and text box designs that complement each other. For example, you can add a matching cover page, header, and sidebar. Click Insert and then choose the elements you want from the different galleries.

Test: PDF Link Lifetime

Description description

More from